We supply medications and train providers to give women safe, comprehensive medical abortion care and contraceptive services.
Medical abortion involves the use of medications to provide safe abortion in countries where abortion is legal – and is a World Health Organization-recommended method – for women up to 12 weeks of gestation.
Medical abortion using a combination of mifepristone and misoprostol is a safe and effective method and preferred by many women to other available options. This method is easy to administer, does not require surgical intervention and can be taken at home, with limited medical supervision.
In countries where abortion is legal – either for broad or specific indications – we ensure that the proper medicines in the proper doses are available and that health care providers are trained and able to give high-quality services, including gestational screening; counseling on pregnancy options; and comprehensive follow-up care such as contraceptive counseling and services.
- Ignite 2017 Annual Report
Project ignite looks further at the total market – informed by rigorous market assessments – and the various actors influencing the end user – to improve and correct underperforming aspects of the market and access to contraception and safe abortion services. This is the 2017 Annual Report that summarizes the key findings, successes, and lessons learned from PSI’s country operations in Haiti, Mozambique, and Cote d’Ivoire, as well as Triggerise’s innovations testing in India and Kenya.
- Ignite and PSI Mozambique’s TEM+ Escolas: Bringing Contraceptive Counseling and Product Delivery to Schools
In Mozambique, PSI’s network of Tem+ clinics are delivering contraceptive counseling and products directly to schools, challenging negative attitudes towards youth access to SRH services while simultaneously creating a positive enabling environment at the service delivery level.
- Ignite 2016 Annual Report
Project ignite looks further at the total market – informed by rigorous market assessments – and the various actors influencing the end user – to improve and correct underperforming aspects of the market and access to contraception and safe abortion services. This is the 2016 Annual Report that summarizes the key findings, successes, and lessons learned from PSI’s country operations in Haiti, Mozambique, and Democratic Republic of Congo, as well as Triggerise’s innovations testing in India and Kenya.
- Establishing a Sustainable Supply Chain for Young People in Haiti
OHMaSS has brokered a unique partnership with commercial distributor DISPROPHAR to incentive the private sector to take responsibility for the FP product category and drive it to scale. Meanwhile, providers are being trained by medical detailers to counsel young clients on contraceptive methods using a Closed Loop Marketing Tool, which strengthens DISPROPHAR’s sales force and helps the program monitor and improve providers’ engagement with their clients. This brief summarizes the key findings, successes, and lessons learned from ignite’s supply-side innovations in Haiti.
- Ignite: Sparking Innovation in Youth-Empowered Healthcare
Project ignite is testing two distinct market approaches as it seeks to break down barriers to access and use of voluntary, modern contraception among girls and young women (ages 15-24). This infographic visually showcases the complementary partnership between PSI and Triggerise.
- Improving Provider Behavior Change Communication and IPC: Best Practices from the Women’s Health Project
This brief describes the challenges faced, strategies developed, and lessons learned by the Women's Health Project. It also proposes a set of best practices for improving productivity of interpersonal communications (IPC) agents and increasing providers' skills and motivation.
- Awareness and Accessibility of Medication Abortions among Women in India
Although the Medical Termination of Pregnancy Act has been under implementation since 1972, unsafe abortions still account for 9% of maternal deaths in India. Medication abortion (MA) is a safe and effective means of early pregnancy termination that provides an alternative to a surgical abortion procedure.